Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 73 for “"dose finding"”.

  1. Adaptive designs for complex dose finding studies

    … phase clinical trial is to find the regimen (dose, combination, schedule, etc.) satisfying particular toxicity or (and) efficacy characteristics. Designs for trials studying doses of a single cytotoxic drug are based on the fundamental assumption "the more the better", that is, the toxicity …

    lancaster Download PDF for Adaptive designs for complex dose finding studies (opens in a new tab)

  2. Innovations in Dose-Finding Designs Using Bayesian Methods

    … about the risk-benefit profile of different doses of the treatment. With this information, researchers select a dose to use for the subsequent phases of development, with the aim of selecting the truly optimal dose. Selecting a sub-optimal dose can have detrimental effects on future clinical …

    umn Repository record for Innovations in Dose-Finding Designs Using Bayesian Methods (opens in a new tab)

  3. Bayesian Phase I Dose Finding In Cancer Trials

    This dissertation explores phase I dose-finding designs in cancer trials from three perspectives: the alternative Bayesian dose-escalation rules, a design based on a time-to-dose-limiting toxicity (DLT) model, and a design based on a discrete-time multi-state (DTMS) model. We list alternative …

    uthsc Repository record for Bayesian Phase I Dose Finding In Cancer Trials (opens in a new tab)

  4. Bayesian Methods in Phase II Dose-Finding Trials

    Characterising the dose-response relationship and finding the right dose are important<br/>but challenging tasks in the pharmaceutical drug development process. The Multiple<br/>Comparison Procedure - Modelling (MCP-Mod) approach is an efficient statistical method<br/>for the analysis of Phase II …

    bristol Repository record for Bayesian Methods in Phase II Dose-Finding Trials (opens in a new tab) Download PDF for Bayesian Methods in Phase II Dose-Finding Trials (opens in a new tab)

  5. Bayesian models for discrete censored sampling and dose finding.

    … of the patient as a function of administered dose using a model that is updated as data accrues. The CRM does not take into consideration the relationship between the toxicity response and the proportion of the administered drug that is absorbed by targeted tissue. Not accounting for this …

    baylor Repository record for Bayesian models for discrete censored sampling and dose finding. (opens in a new tab)

  6. Optimal designs for dose-finding in contingent response models

    We study D- and c-optimal designs for dose-finding with opposing failure functions. In particular, we study the contingent response models of Li, Durham and Flournoy (1995). In the contingent response model, there are two opposing types of failure. We call one failure type toxicity and the other …

    missouri Repository record for Optimal designs for dose-finding in contingent response models (opens in a new tab)

  7. Dual-Criterion Dose Finding Designs for Phase I Clinical Trials

    … tolerability of novel therapeutics. Conventional dose escalation methods identify the maximum tolerated dose (MTD) based on dose-limiting toxicity (DLT). However, as cancer therapies have evolved from chemotherapy to targeted therapies, these traditional methods have become problematic. Many …

    uthsc Repository record for Dual-Criterion Dose Finding Designs for Phase I Clinical Trials (opens in a new tab)

  8. Bayesian Adaptive Dose-Finding Clinical Trial Designs with Late-Onset Outcomes

    … outcome issue is common in early phase dose- nding clinical trials. This problem becomes more intractable in phase I/II clinical trials because both toxicity and e cacy responses are subject to the late-onset outcome issue. The existing methods applying for the phase I trials cannot be …

    iupui Repository record for Bayesian Adaptive Dose-Finding Clinical Trial Designs with Late-Onset Outcomes (opens in a new tab)

  9. Bayesian Semi-Mechanistic Dose-Finding Designs For Phase I Oncology Trials

    … In oncology, despite the great advances in novel dose-finding designs, the high failure rates of clinical cancer drug development from phase I to III trials call for further improvements on novel designs, in addition to the need to promote and adopt novel designs in practice. Because anticancer …

    uthsc Repository record for Bayesian Semi-Mechanistic Dose-Finding Designs For Phase I Oncology Trials (opens in a new tab)

  10. An Adaptive Dose Finding Design (DOSEFIND) Using A Nonlinear Dose Response Model

    … trials are the first time that an NCE is dosed in human subjects, the designs used in these trials are unique and geared toward patient safety. We develop a method for obtaining the desired response using an adaptive non-linear approach. This method is applicable for studies in which MTD, …

    vcu Repository record for An Adaptive Dose Finding Design (DOSEFIND) Using A Nonlinear Dose Response Model (opens in a new tab)

  11. Two stage adaptive optimal design with applications to dose-finding clinical trials

    In adaptive optimal designs, each stage uses an estimate of the locally optimal design derived using cumulative data from all prior stages. This dependency on prior stages a ffects the properties of maximum likelihood estimates. To illuminate the eff ects, we assume for simplicity a nonlinear …

    missouri Repository record for Two stage adaptive optimal design with applications to dose-finding clinical trials (opens in a new tab)

  12. Application of the Continual Reassessment Method for Dose Finding Studies in Regional Anaesthesia

    I conducted five dose-finding studies as three different treatment arms of one clinical trial. The primary objective of this prospective randomised, double-blind trial was to estimate the ED95 of: (1) 1% and 2% lidocaine with adrenaline for axillary plexus blocks, (2) 1% prilocaine and 1% lidocaine …

    whiterose Download PDF for Application of the Continual Reassessment Method for Dose Finding Studies in Regional Anaesthesia (opens in a new tab)

  13. Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study

    … In this multicenter, open-label, phase I dose finding clinical trial, pemetrexed was investigated as a single agent treatment for primary or secondary CNSL. RESULTS: A total of 18 patients were enrolled between January 2009 and November 2014. The mean age was 64.6 years old (range: 47-79). …

    bu Repository record for Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study (opens in a new tab)

  14. Adaptive optimal designs for dose-finding studies and an adaptive multivariate CUSUM control chart

    … development of a new drug, where a conventional dose- finding study involves learning about the dose-response curve in order to bring forward right doses of drug to late-stage development. The first part of this dissertation focus on three pharmacodynamics sigmoid Emax models, we derive the …

    missouri Repository record for Adaptive optimal designs for dose-finding studies and an adaptive multivariate CUSUM control chart (opens in a new tab)

  15. Developments to established dose-finding methodologies for application in trials with complex and innovative designs

    … This thesis explores methodologies used in dose-finding trials, specifically looking at the implementation of these methods and how they can be extended to answer different questions and assist with decision-making. Firstly we detail our experiences implementing a novel methodology for a …

    birmingham Download PDF for Developments to established dose-finding methodologies for application in trials with complex and innovative designs (opens in a new tab)

  16. Dose finding procedures in Phase II clinical studies (Διαδικασίες εύρεσης δόσης σε κλινικές δοκιμές Φάσης ΙΙ)

    Η ανάλυση των σχέσεων δόσης-απόκρισης βασίζεται στην υπόθεση ότι η επίδραση ενός φαρμάκου εξαρτάται από την ποσότητα του φαρμάκου, που χορηγείται στον ασθενή. Η αναζήτηση μιας επαρκούς δόσης προκειμένου να αναπτυχθεί ένα κλινικά βιώσιμο φαρμακευτικό προϊόν περιλαμβάνει μία σειρά από σύνθετες …

    athens Repository record for Dose finding procedures in Phase II clinical studies (Διαδικασίες εύρεσης δόσης σε κλινικές δοκιμές Φάσης ΙΙ) (opens in a new tab)

  17. Ankle exercises via Mirror Therapy after stroke: co-design of the equipment, who might benefit, and dose-finding.

    … of the device and what might be an appropriate dose of therapy. A systematic review was conducted to elucidate current knowledge on the effect of LLMT motor recovery (Study I). The review examined the influence of time after stroke, level of paresis, and dose of therapy on recovery. The review …

    east-anglia Download PDF for Ankle exercises via Mirror Therapy after stroke: co-design of the equipment, who might benefit, and dose-finding. (opens in a new tab)

  18. A Bayesian Approach to Dose-finding Studies for Cancer Therapies: Producing Personalised Procedures While Incorporating Information from Later Cycles of Therapy.

    Bayesian model based approaches for Phase I dose-finding studies are popular procedures to implement due to the efficiency of updating information sequentially after accruing information. Traditionally dose-finding studies for cancer treatments focus on the occurrence of a patient's first dose …

    lancaster Download PDF for A Bayesian Approach to Dose-finding Studies for Cancer Therapies: Producing Personalised Procedures While Incorporating Information from Later Cycles of Therapy. (opens in a new tab)

  19. Dose in stroke rehabilitation trials

    Background: the dose and the length of rehabilitative interventions for optimal motor recovery after stroke are unknown. Dose optimization studies are required as precursors to efficacy trials, but are rarely conducted in stroke rehabilitation research. Objective: to overcome the knowledge gap on …

    east-anglia Download PDF for Dose in stroke rehabilitation trials (opens in a new tab)

  20. The application of Bayesian adaptive design and Markov model in clinical trials

    … The first problem is a new Bayesian adaptive dose-finding design and its application in an oncology clinical trial. This design is used for phase IB studies with the biomarker as the endpoint and with the fewer patients. The second problem is another new Bayesian adaptive dose-finding design …

    njit Repository record for The application of Bayesian adaptive design and Markov model in clinical trials (opens in a new tab)

Page 1 of 4